151 related articles for article (PubMed ID: 7540960)
1. Histopathological and immunohistochemical analysis of adenomatous hyperplasia and hepatocellular carcinoma: cellularity, thickness of cell cord, and Ki-67 proliferative activity.
Than KW; Okayasu I; Akashi T
Bull Tokyo Med Dent Univ; 1995 Jun; 42(2):67-81. PubMed ID: 7540960
[TBL] [Abstract][Full Text] [Related]
2. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
3. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
4. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.
Kaji K; Terada T; Nakanuma Y
Am J Gastroenterol; 1994 Jun; 89(6):903-8. PubMed ID: 8198103
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological significance of adenomatous hyperplasia of the liver].
Nakashima O; Kojiro M
Nihon Rinsho; 1994 Jan; 52(1):75-9. PubMed ID: 8114314
[TBL] [Abstract][Full Text] [Related]
6. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
Terada T; Hoso M; Nakanuma Y
Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of hepatitis C virus core antigen and HBxAg in liver cirrhosis and hepatocellular carcinoma tissues].
Wang C; Wang W; Lu H
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):85-8. PubMed ID: 10743066
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
[TBL] [Abstract][Full Text] [Related]
9. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
10. [Precancerous stages of hepatocellular carcinoma].
Tanikawa K
Gan To Kagaku Ryoho; 1995 Dec; 22(14):2055-61. PubMed ID: 8607615
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
[TBL] [Abstract][Full Text] [Related]
12. [Pathomorphologic characteristics and differential diagnosis of small hepatocellular carcinoma].
Nakashima O; Kojiro M
Gan To Kagaku Ryoho; 1996 Jun; 23(7):827-34. PubMed ID: 8678529
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of telomerase activity in precancerous lesion of the liver (adenomatous hyperplasia)].
Nishimoto A; Miura N; Oshimura M
Nihon Rinsho; 1998 May; 56(5):1244-7. PubMed ID: 9613131
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen.
Terada T; Nakanuma Y
Cancer; 1992 Aug; 70(3):591-8. PubMed ID: 1352480
[TBL] [Abstract][Full Text] [Related]
15. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
[TBL] [Abstract][Full Text] [Related]
17. Pathomorphologic comparison of hepatitis C virus-related and hepatitis B virus-related cirrhosis bearing hepatocellular carcinoma.
Kojiro M; Shimamatsu K; Kage M
Princess Takamatsu Symp; 1995; 25():179-84. PubMed ID: 8875623
[TBL] [Abstract][Full Text] [Related]
18. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
19. Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma.
Morinaga S; Ishiwa N; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
J Surg Oncol; 2005 Dec; 92(4):331-6. PubMed ID: 16299800
[TBL] [Abstract][Full Text] [Related]
20. CD 34 expression in chronic and neoplastic liver diseases.
Di Carlo I; Fraggetta F; Lombardo R; Azzarello G; Vasquez E; Puleo S
Panminerva Med; 2002 Dec; 44(4):365-7. PubMed ID: 12434120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
